179 related articles for article (PubMed ID: 34776937)
1. Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
Yu L; Huo Z; Yang J; Palma-Gudiel H; Boyle PA; Schneider JA; Bennett DA; Zhao J
Front Aging Neurosci; 2021; 13():765259. PubMed ID: 34776937
[TBL] [Abstract][Full Text] [Related]
2. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease-Related Dementias Summit 2022: National Research Priorities for the Investigation of Post-Traumatic Brain Injury Alzheimer's Disease and Related Dementias.
Dams-O'Connor K; Awwad HO; Hoffman S; Pugh MJ; Johnson VE; Keene CD; McGavern L; Mukherjee P; Opanashuk L; Umoh N; Sopko G; Zetterberg H
J Neurotrauma; 2023 Aug; 40(15-16):1512-1523. PubMed ID: 36927167
[TBL] [Abstract][Full Text] [Related]
4. The Cerebrospinal Fluid Free-Glycans Hex
Krüger L; Biskup K; Schipke CG; Kochnowsky B; Schneider LS; Peters O; Blanchard V
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785920
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS Isomeric Profiling of
Reyes CDG; Hakim MA; Atashi M; Goli M; Gautam S; Wang J; Bennett AI; Zhu J; Lubman DM; Mechref Y
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359007
[TBL] [Abstract][Full Text] [Related]
6. Characterization of N-glycome profile in mouse brain tissue regions by MALDI-TOF/MS.
Liu Y; Han Y; Zhu W; Luo Q; Yuan J; Liu X
Anal Bioanal Chem; 2023 Sep; 415(23):5575-5588. PubMed ID: 37452841
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease-Related Dementias Summit 2019: National Research Priorities for the Investigation of Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease and Related Dementias.
Dams-O'Connor K; Bellgowan PSF; Corriveau R; Pugh MJ; Smith DH; Schneider JA; Whitaker K; Zetterberg H
J Neurotrauma; 2021 Dec; 38(23):3186-3194. PubMed ID: 34714152
[TBL] [Abstract][Full Text] [Related]
8. Early Stage Glycosylation Biomarkers in Alzheimer's Disease.
Regan P; McClean PL; Smyth T; Doherty M
Medicines (Basel); 2019 Sep; 6(3):. PubMed ID: 31484367
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and related dementias and heart failure: A community study.
Manemann SM; Knopman DS; St Sauver J; Bielinski SJ; Chamberlain AM; Weston SA; Jiang R; Roger VL
J Am Geriatr Soc; 2022 Jun; 70(6):1664-1672. PubMed ID: 35304739
[TBL] [Abstract][Full Text] [Related]
10. Regio-Specific N-Glycome and N-Glycoproteome Map of the Elderly Human Brain With and Without Alzheimer's Disease.
Tena J; Maezawa I; Barboza M; Wong M; Zhu C; Alvarez MR; Jin LW; Zivkovic AM; Lebrilla CB
Mol Cell Proteomics; 2022 Nov; 21(11):100427. PubMed ID: 36252735
[TBL] [Abstract][Full Text] [Related]
11. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
12. CSF N-glycoproteomics for early diagnosis in Alzheimer's disease.
Palmigiano A; Barone R; Sturiale L; Sanfilippo C; Bua RO; Romeo DA; Messina A; Capuana ML; Maci T; Le Pira F; Zappia M; Garozzo D
J Proteomics; 2016 Jan; 131():29-37. PubMed ID: 26455811
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Risk of Alzheimer's Disease and Related Dementia in Patients with Mild Cognitive Impairment Using a Semi-Competing Risk Approach.
Chen Z; Yang Y; Zhang D; Guo J; Guo Y; Hu X; Chen Y; Bian J
Informatics (MDPI); 2023 Jun; 10(2):. PubMed ID: 38919750
[TBL] [Abstract][Full Text] [Related]
14. Region-Specific Cell Membrane N-Glycome of Functional Mouse Brain Areas Revealed by nanoLC-MS Analysis.
Barboza M; Solakyildirim K; Knotts TA; Luke J; Gareau MG; Raybould HE; Lebrilla CB
Mol Cell Proteomics; 2021; 20():100130. PubMed ID: 34358619
[TBL] [Abstract][Full Text] [Related]
15. The association between cognitive ability and opioid prescribing in vulnerable older adults with chronic pain in ambulatory care: a secondary data analysis using the Medical Expenditure Panel Survey.
Muench U; Kim KM; Zimmer Z; Monroe TB
BMC Med; 2023 Nov; 21(1):446. PubMed ID: 37974164
[TBL] [Abstract][Full Text] [Related]
16. Mid-life leukocyte telomere length and dementia risk: An observational and mendelian randomization study of 435,046 UK Biobank participants.
Liu R; Xiang M; Pilling LC; Melzer D; Wang L; Manning KJ; Steffens DC; Bowden J; Fortinsky RH; Kuchel GA; Rhee TG; Diniz BS; Kuo CL
Aging Cell; 2023 Jul; 22(7):e13808. PubMed ID: 37254630
[TBL] [Abstract][Full Text] [Related]
17. Predicting Alzheimer's Disease and Related Dementias in Heart Failure and Atrial Fibrillation.
Manemann SM; Chamberlain AM; Bielinski SJ; Jiang R; Weston SA; Roger VL
Am J Med; 2023 Mar; 136(3):302-307. PubMed ID: 36502953
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of exercise interventions targeting sleep in older adults with cognitive impairment or Alzheimer's disease and related dementias (AD/ADRD): A systematic review and meta-analysis.
Páez A; Frimpong E; Mograss M; Dang-Vu TT
J Sleep Res; 2024 Mar; ():e14189. PubMed ID: 38462491
[TBL] [Abstract][Full Text] [Related]
19. Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans.
Jutkowitz E; Bynum JPW; Mitchell SL; Cocoros NM; Shapira O; Haynes K; Nair VP; McMahill-Walraven CN; Platt R; McCarthy EP
Alzheimers Dement (Amst); 2020; 12(1):e12048. PubMed ID: 32647744
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.
Dover M; Moseley T; Biskaduros A; Paulchakrabarti M; Hwang SH; Hammock B; Choudhury B; Kaczor-Urbanowicz KE; Urbanowicz A; Morselli M; Dang J; Pellegrini M; Paul K; Bentolila LA; Fiala M
J Alzheimers Dis; 2023; 91(1):245-261. PubMed ID: 36373322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
